Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,831,528
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
748,773
-
Shares change
-
+37,384
-
Total reported value, excl. options
-
$1,064,069
-
Value change
-
+$47,078
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$1.42
Significant Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q1 2025
25 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 748,773 shares
of 13,831,528 outstanding shares and own 5.41% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (275,656 shares), RENAISSANCE TECHNOLOGIES LLC (125,628 shares), BlackRock, Inc. (73,746 shares), GEODE CAPITAL MANAGEMENT, LLC (73,119 shares), NEUBERGER BERMAN GROUP LLC (59,271 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (33,683 shares), STATE STREET CORP (20,543 shares), UBS Group AG (16,806 shares), Parallel Advisors, LLC (15,228 shares), and DIMENSIONAL FUND ADVISORS LP (14,596 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.